Study objective: To establish the prevalence of pulmonary embolism (PE) in autopsy material at a tertiary cardiac referral center and its importance as a cause of death in patients with heart disease (HD). Design: Case series. Setting: National Heart Institute, Mexico City. Patients: One thousand thirty-two patients who died at our institution from 1985 to 1994 in whom an autopsy study was performed. Measurements and results: Of the 1,032 autopsies reviewed, 231 cases (24.4%) of PE were found; 100 of these patients had a diagnosis of massive PE. Massive PE (obstruction of either of the main pulmonary arteries or more than two lobar arteries) was found to be the third cause of death in this HD population. By age-group distribution, the global prevalence of massive events was higher in patients < 10 years old. Clinical suspicion (premortem) was raised in only 18% of the cases. Conclusions: PE was a frequent cause of morbidity and mortality in patients with HD who underwent autopsies. The incidence of massive PE was high in children.
A n association between heart disease (HD) and arterial thromboembolism has been previously identified [1] [2] [3] ; however, the relationship between HD and venous thromboembolism (VTE) is less clear. Establishing the prevalence of pulmonary embolism (PE) among HD patients is difficult because of several factors. First, the main symptoms (dyspnea and chest pain) and signs (tachycardia and tachypnea) of PE are also common in the setting of HD patients. Second, results of auxiliary diagnostic studies such as arterial blood gases, chest radiography, ECG, and ventilation/perfusion scanning are frequently abnormal in HD patients and, therefore, nonspecific. Finally, complementary studies such as impedance plethysmography and B-mode compression ultrasonography for the diagnosis of deep vein thrombosis (DVT) are of limited diagnostic value in this population. 4 Accordingly, we have reviewed the postmortem material at our institution in order to establish the prevalence of PE and its importance as a cause of death in this population.
Materials and Methods
We reviewed both the clinical charts and the reports of the postmortem studies of patients who had undergone autopsies at the National Heart Institute of Mexico City during 1985 to 1994. We analyzed the demographics, clinical characteristics, diagnosis, and the cause of death of these patients.
From the autopsy protocols, we determined the prevalence of PE in this patient material and, based on the magnitude of the obstructed pulmonary vasculature, whether PE had been the direct or primary cause of death (massive PE), defined as (1) obstruction of either main pulmonary arteries, 5 (2) obstruction of more than two lobar arteries, 6 without any other identifiable cause that could have contributed to death, or whether PE had been identified as a secondary cause of death (nonmassive PE), that is, obstruction of less than two lobar arteries related to other, more specific causes that could have contributed to death. We also established whether gross myocardial abnormalities (ischemia, infarction, hypertrophy, and dilatation) in either the right or left ventricles were present in the hearts of patients dying from massive PE.
From the clinical charts, we established whether the diagnosis of PE was made or at least suspected antemortem, and whether the patients had received any form of antithrombotic prophylaxis and/or treatment. Finally, we analyzed the clinical manifestations of the patients who died from massive PE.
According to their baseline etiologic diagnoses, HD patients were classified into four groups: ischemic heart disease, congenital HD (CHD), valvular HD, and other HDs (this last group included patients with hypertensive HD, cor pulmonale, peripheral vascular disease). Each of these groups were further subclassified into medical or surgical patients; the latter group included patients admitted to the hospital for elective or emergency surgery and in whom death occurred in the perioperative period.
Results
From a total group of 3,751 patients during the decade from 1985 to 1994, 1,032 autopsies (27.5%) were performed. Over the years, the number of autopsies performed remained relatively constant, between 20% and 30% of the total number of deaths. A total of 231 cases of PE were found in this material for an overall prevalence of 22.4%; 100 of these 231 cases (9.7% of the 1,032 autopsies) corresponded to the diagnosis of massive PE with a mean age of 35.2 Ϯ 26.7 years (Ϯ SD). Table 1 shows the distribution of the autopsies according to baseline cardiac diagnosis and gender. Total numbers of autopsies among ischemic, valvular, and congenital groups were relatively equally distributed.
The principal causes of death in the total population are shown in Table 2 . Overall, massive PE was found to be the third cause of death (100 patients). In 32.4% of the cases (335 patients), the pathologist could not attribute the cause of death to a morphologic anomaly. Table 3 shows the distribution of autopsies according to HD in the surgical and medical groups; 290 autopsies were performed in patients Ͻ 10 years old. Fifty-eight percent of patients who died from massive PE were in the medical subgroup, and 42% were surgical patients. The highest prevalence of massive PE, was found in the "other" HD category (16.2%), and most of them were seen in the medical group. Diseases included in this category are those listed in Table 4 . This category also included cases with pneumonia (n ϭ 5), pulmonary valve stenosis (n ϭ 20), valvular fibroelastosis (n ϭ 2), aortic sclerosis (n ϭ 1), aortic hypoplasia (n ϭ 1), pericarditis (n ϭ 1), hemorrhagic shock (n ϭ 1), heart failure (n ϭ 1), rabies (n ϭ 1), Chagas disease (n ϭ 1), and hepatitis (n ϭ 1).
When analyzing the patients with a massive PE event by age-group distribution, we found that the global prevalence was higher in patients Ͻ 10 years old, especially in the medical group. In the surgical group, massive events were more frequently in patients within the age groups of 10 to 19 years and Ͼ 60 years old (Fig 1) .
Of the 100 patients who had massive PE, 32 patients were receiving some form of anticoagulation at the moment of the event. Premortem clinical suspicion of PE was raised only in 18%. Sixty-four of these 100 patients complained about dyspnea; of these, 14 patients required mechanical ventilation due to acute respiratory failure. Nineteen patients complained of chest pain, 89 patients had tachycardia and/or tachypnea, and 79 patients had systemic arterial hypotension. There were no reports of either dyspnea or chest pain in 23 patients. Most of these patients were Ͻ 10 years old or were receiving mechanical ventilation for other reasons (ie, patients transferred to the surgical ICU and received mechanical ventilation). The cardiac rhythms found at the time of the event were ventricular fibrillation (n ϭ 31), sinus tachycardia (n ϭ 24), ventricular tachycardia (n ϭ 23), sinus bradycardia (n ϭ 11), atrial fibrillation (n ϭ 6), asystole (n ϭ 3), and atrioventricular block (n ϭ 2). Nine patients with massive PE also had pathologic evidence of a recent myocardial infarction: left ventricle (n ϭ 5), right ventricle (n ϭ 2), and biventricular (n ϭ 2). The rest of the cardiac pathology findings are shown in Table 5 . 
Discussion
PE was an important cause of morbidity and mortality in patients during the decade from 1985 to 1994 at our institution. It is important to point out that of the 3,751 patients who died during our study period, 1,032 had an autopsy performed; ie, one autopsy was performed in 3 to 4 patients who died, a relatively high percentage that gives confidence to our findings. PE occurred in 22.4% of patients and was the leading cause of death in 9.7%. These figures represent the prevalence of PE in patients with HD who, for some reason, underwent autopsies, and they do not necessarily reflect the true prevalence of PE in the HD population. However, the total incidence of 9.7% does not differ from previous reports. [7] [8] [9] [10] Arterial thromboembolism is a known complication in patients with atrial fibrillation. Likewise, CHF has been identified as a risk factor for VTE. 1, 2 It has been reported that patients with CHF have an incidence of any kind of thromboembolic event of 2.2 to 2.5 per 100 patient-years, 1 and the incidence of clinically apparent PE was estimated to be 0.3 per 100 patient-years. Also, one study 11 has shown that patients with CHF have evidence of increased platelet and thrombin activation and increased fibrinolytic activity. These abnormalities are most pronounced with severe heart failure, supporting the hypothesis that a prethrombotic state exists in this condition. In a North American study 12 that included 1,231 patients with the diagnosis of VTE, heart failure and myocardial infarction were found as comorbid conditions in 8.2% and 0.7%, respectively. Similarly, in a European study 13 of 1,001 patients with established PE, 32% had a diagnosis of CHF. However, it has not been clearly established whether patients with other types of heart disease have a high risk for VTE.
At our institution, Flores et al 14 reviewed 86 patients who had PE confirmed by angiography (18%) and/or autopsy (82%). They found that these patients had a high frequency of rheumatic HD as the baseline diagnosis (76%), which might reflect the prevalence of this disease in our country. Karwinski and Svendsen 3 also found a higher incidence of PE in patients with rheumatic HD as compared with patients with ischemic HD, and they concluded that these patients probably had a variable degree of CHF resulting in venous stasis and edema. 3 In most of the previously published studies, the incidence of PE has been reported to increase with age. The analysis of the prevalence of massive PE in our study population showed that the events were high in children Ͻ 10 years old, most of them with CHD; this was an unexpected finding. Recently, VTE has been recognized as a major complication in children and young adults. 15, 16 The incidence of VTE during childhood, as analyzed in two populationbased studies, 15, 17 has been estimated to be 240 per 100,000 hospital admissions for neonates and 53 per 100,000 admissions for older children. The most important risk factor for thrombosis in pediatric patients is a central venous line, and CHD is one of the most common underlying disorders. 15, 17 VTE associated with heterozygous antithrombin deficiency or Factor V Leiden mutation has been described in children and usually occurs following a significant acquired risk factor or disorder. 15 The true incidence of PE in children is unknown. However, the incidence of PE in children with documented DVT has been reported to be from 30 to 60%, which is similar to that of adults with DVT. 6, 15 It is clear that this age group represents a diagnostic challenge because children often cannot express clear symptoms (such as shortness of breath), and they have an excellent cardiopulmonary reserve that makes them less susceptible to hemodynamic compromise. 15 Our population, however, was that of children with HD who very likely did not have a good cardiopulmonary reserve. In adults with CHD, pulmonary thromboembolism is also an important cause of morbidity/mortality. 18 Our study did not show any difference with published reports 7, 13 regarding gender characteristics, PE being slightly more frequent in male than in female patients. There was also a greater incidence of massive PE events in the medical group rather than in the surgical group. Thirty-two percent of our patients with massive PE were receiving some form of anticoagulation (either heparin or oral anticoagulants) at the moment of the event. However, the indications and the level of anticoagulation at the time are not known to us and hence, we cannot exclude inadequate anticoagulation as a contributory factor in the occurrence of the thromboembolic episodes.
Traditionally, life-threatening PE has been equated with anatomically massive PE. 6 We recognize that the outcome of massive PE is a function of the cardiopulmonary reserve and of the size of the embolus. 6 Most of the patients in our study had a poor cardiovascular reserve. Massive PE was the third overall cause of death in our study. One hundred patients died from massive embolism. The clinical picture was similar to that previously reported in the general population. Dyspnea was the most common symptom, and tachypnea and tachycardia were the most common physical findings. In our study, however, 79% of patients who died from massive PE had systemic hypotension prior to death; therefore, unexplained systemic arterial hypotension should be added to the clinical suspicion of PE in HD patients.
It has been demonstrated that patients with acute PE can have a wide range of abnormalities regarding the right ventricular function. Systemic hypotension could have been due to a phenomenon of ventricular interdependence and decreased left ventricular filling. 18 In the setting of massive PE, there may also exist an associated decrease in coronary perfusion pressure that may produce myocardial ischemia and, potentially, right ventricular infarction. 19, 20 Interestingly, right and left ventricular abnormalities including chamber dilatation and infarction were found at autopsy in some of our patients. In the International Cooperative Pulmonary Embolism Registry study, 9 among those patients who underwent echocardiography, the findings of right ventricular dilatation and hypokinesis were associated with an increased mortality rate. Less clear is the relationship between right ventricular infarction and massive PE. Typically, isolated right ventricular infarction is associated with atherosclerotic disease of the acute marginal vessels or of a nondominant right coronary artery, but it may occur in the absence of coronary disease when substantial right ventricular hypertrophy is present (ie, pulmonary vascular disease). 21 The association of right ventricular infarction and massive PE as a determinant of mortality has been recently addressed, 22 but more studies are needed to establish the precise nature of this relationship.
Our study is limited by its retrospective nature and by the fact that several pathologists were involved over a 10-year period in the initial assessment of the autopsy findings, even though the final analysis was performed by only one pathologist (A.A.). Ideally, evidence regarding the incidence of PE among HD patients should come from a prospective cohort study.
